Cumulative experimental evidence has proved that natural and synthetic PPAR-γ ligands can inhibit major signaling pathways of inflammation such as NF-κB, which underlies many aspects of the anti-inflammatory effect of PPAR-γ, and reduce the synthesis of cartilage catabolic factors responsible for articular cartilage degradation in arthritis. Here, PPARG is linked to arthritic joint disease.